37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers

Key Takeaways Explain This Topic AI

Reversible pulpitis produces transient, stimulus-evoked pain (<15 seconds) triggered by thermal or sweet foods that resolves immediately upon stimulus removal, requiring conservative dental restoration; irreversible pulpitis causes severe, spontaneous, continuous throbbing toothache persisting for minutes to hours (often nocturnal), requiring endodontic root canal therapy or extraction, with analgesics rather than antibiotics indicated for pain.

Periapical abscess represents the extension of pulpal necrosis through the tooth apical foramen into alveolar bone, causing exquisite percussion tenderness; in immunocompetent patients without systemic signs, definitive therapy is urgent dental drainage or root canal—systemic oral antibiotics are indicated ONLY when systemic symptoms (fever, cellulitis, lymphadenopathy, trismus) are present.

When antibiotics are indicated for spreading odontogenic infections, first-line oral regimens are amoxicillin 500 mg TID or amoxicillin-clavulanate 875/125 mg BID for 5-7 days; in penicillin-allergic patients, oral clindamycin 300-450 mg TID or oral azithromycin 500 mg day 1 then 250 mg daily is recommended.

Ludwig angina is a life-threatening, rapidly expanding bilateral cellulitis/phlegmon of the submandibular, sublingual, and submental spaces typically arising from mandibular second or third molar root infections; hallmark signs include woody submandibular induration, floor of mouth elevation, and tongue protrusion causing catastrophic airway obstruction, mandating immediate awake fiberoptic intubation or tracheostomy, broad-spectrum IV antibiotics, and surgical consultation.

Recurrent aphthous stomatitis (canker sores) manifests as painful shallow ulcers with a yellow-gray pseudomembrane and erythematous halo located strictly on non-keratinized mobile mucosa (buccal mucosa, ventral tongue), treated with topical high-potency corticosteroids (triamcinolone in Orabase); systemic screening (celiac disease, Crohn disease, Behçet disease, B12/folate deficiency) is warranted for complex or refractory cases.

Last updated: September 2026

Spectrum of Acute Odontogenic Conditions

Odontogenic pain and infections account for millions of primary care and emergency department visits annually. Primary care clinicians must distinguish self-limited pulpal inflammation from deep tissue infections requiring urgent dental intervention, while applying rigorous antimicrobial stewardship principles to curb the widespread overprescription of unnecessary antibiotics for localized toothaches. SPECTRUM OF ODONTOGENIC PATHOLOGY

• Dental Caries ───────> Reversible Pulpitis ───────> Irreversible Pulpitis
• (Enamel/Dentin) • Pain <15 sec with cold/sweet • Spontaneous throbbing pain
• Resolves on stimulus removal • Lingers >30 sec to hours
• Tooth vital; Dental filling • Nocturnal awakening
• Root canal or extraction
• │
• ▼
• Ludwig Angina <─────── Facial Cellulitis <─────── Periapical Abscess
• (Deep Neck Infection) (Spreading Infection) • Pulpal necrosis through apex
• Mandibular 2nd/3rd • Systemic signs • Exquisite percussion tenderness
• Submandibular woody • ANTIBIOTICS INDICATED: • Gumboil / fluctuance
• AIRWAY EMERGENCY! Amox-Clav or Clindamycin • Drainage / Root canal
• 1. Reversible Pulpitis

Pathophysiology : Dental caries penetrates the enamel and invades the dentin , exposing microscopic dentinal tubules. Fluid movement within these tubules stimulates mechanoreceptors and A-delta sensory nerve fibers in the dental pulp. The pulpal tissue is hyperemic and inflamed but remains vital, vascularized, and capable of complete repair once the irritant is removed.

Clinical Presentation :

Mild to moderate, sharp, transient pain provoked by external stimuli: cold liquids, hot foods, sweets, or sour foods.

The pain lasts only seconds (<10 to 15 seconds) and resolves immediately upon removal of the offending stimulus .

Absence of spontaneous, unprovoked tooth pain.

Absence of pain with tooth percussion or chewing.

Management :

Routine dental referral for restorative dental filling (removal of decayed dentin and sealing with composite resin or amalgam).

Analgesics are generally unnecessary or limited to over-the-counter NSAIDs (e.g., ibuprofen 400 mg PRN).

Antibiotics are strictly NOT indicated .

2. Irreversible Pulpitis

Pathophysiology : Carious destruction breaches the pulp chamber directly, allowing polymicrobial bacterial invasion of the vascularized dental pulp. Severe acute inflammation inside the rigid, non-compliant dentin chamber leads to elevated intraluminal pulpal pressure, microvascular collapse, pulpal ischemia, microabscess formation, and progressive liquefactive necrosis.

Clinical Presentation :

Severe, intense, spontaneous, continuous, or throbbing toothache.

Pain persists for prolonged periods (minutes to hours, often >30 seconds to several minutes) after thermal stimulation .

Heat characteristically exacerbates the pain; in advanced stages with gas-producing anaerobic necrosis, cold liquids may paradoxically alleviate the pain temporarily by contracting trapped gases.

Nocturnal pain that awakens the patient from sleep is a classic hallmark.

Pain is often poorly localized or referred along branches of the trigeminal nerve (V2 maxillary or V3 mandibular).

In later stages, extension to the apical periodontal ligament produces mild sensitivity to percussion.

Management :

Definitive Treatment : Urgent dental referral for pulpectomy (complete extirpation of the pulpal tissue / initial stage of root canal therapy) or tooth extraction .

Analgesia : First-line medical therapy is scheduled non-steroidal anti-inflammatory drugs: Oral Ibuprofen 400 to 600 mg every 6 hours combined or alternated with Oral Acetaminophen 500 to 1,000 mg every 6 hours . Randomized trials show NSAIDs provide superior analgesia compared to opioids for pulpal pain by directly inhibiting tissue prostaglandins.

Antibiotic Stewardship Rule : Systemic antibiotics are strictly NOT indicated for irreversible pulpitis without systemic spread! Antibiotics do not relieve odontogenic pain, cannot penetrate the devascularized necrotic pulp chamber, and do not prevent progression to periapical disease without mechanical pulpal debridement.

3. Periapical Abscess (Alveolar Abscess)

Pathophysiology : Complete necrosis of the dental pulp allows polymicrobial oral flora (predominantly obligate anaerobes: Peptostreptococcus , Prevotella , Porphyromonas , Fusobacterium , and viridans streptococci) to exit through the apical foramen of the tooth root into the surrounding periapical alveolar bone and periodontal ligament. The resulting intense neutrophilic response creates a localized purulent collection.

Clinical Presentation :

Severe, constant, intense, localized, throbbing tooth pain.

Exquisite tenderness to light tapping or percussion of the tooth (pathognomonic sign of periapical inflammation).

Sensation that the offending tooth is "elongated," "raised," or extruded in its socket , making gentle contact with opposing teeth excruciating.

Localized, fluctuant, erythematous swelling of the buccal gingiva adjacent to the root apex ( parulis or "gumboil" ); spontaneous rupture releases foul-tasting pus, producing dramatic immediate pain relief.

Tender regional submandibular or cervical lymphadenopathy.

Management & Antibiotic Stewardship :

Primary Management : Urgent dental referral for definitive source control : endodontic drainage (trephination through the tooth crown), tooth extraction, or incision and drainage (I&D) of fluctuant submucosal gingival abscesses.

When Antibiotics ARE Indicated :

• Evidence of systemic spread : fever (temperature ≥38.0°C), tachycardia, chills, diaphoresis, malaise;
• Spreading facial cellulitis or diffuse soft-tissue swelling;
• Trismus (inability to open the mouth normally, interincisal opening <35 mm);
• Extension to regional fascial spaces or deep cervical chains;

Severely immunocompromised host (neutropenia, advanced HIV/AIDS, active chemotherapy, organ transplant).

First-Line Antimicrobial Regimens (when systemic criteria are met):

Oral Amoxicillin : 500 mg orally three times daily (TID) for 5 to 7 days ; OR

Oral Amoxicillin-Clavulanate (Augmentin) : 875/125 mg orally twice daily (BID) for 5 to 7 days (preferred if refractory or previous beta-lactam exposure due to beta-lactamase-producing anaerobes);

In Penicillin-Allergic Patients :

Oral Clindamycin : 300 to 450 mg orally three to four times daily for 5 to 7 days (covers oral Gram-positive cocci and oral anaerobes; monitor for C. difficile );

Oral Azithromycin : 500 mg orally on day 1, then 250 mg once daily on days 2 through 5 ;

Oral Cephalexin : 500 mg orally four times daily (acceptable only for mild, non-anaphylactic, non-IgE mediated penicillin reactions).

Summary: Comparison of Common Odontogenic Conditions

Condition Pathologic Anatomy Pain Characteristics Percussion Sensitivity Definitive Therapy Antibiotics Indicated?

Reversible Pulpitis Dentin exposure; vital, inflamed pulp Transient (<15 sec) with thermal/sweet; stops immediately on stimulus removal Absent Dental filling / restorative sealing NO

Irreversible Pulpitis Direct bacterial pulpal invasion; pulpal necrosis Spontaneous, throbbing, continuous; lingers >30 sec to hours; nocturnal awakening Mild or absent Pulpectomy (root canal) or extraction NO (unless systemic spread)

Periapical Abscess Purulent spread through apex into alveolar bone Intense localized throbbing pain; tooth feels elevated/extruded in socket Exquisite (severe pain on light tapping) Endodontic drainage, extraction, or gingival I&D ONLY if systemic spread , fever, cellulitis, trismus, or immunocompromised

Deep Neck Space Infections: Ludwig Angina

Ludwig angina is a rapidly spreading, potentially catastrophic bilateral cellulitis and phlegmon involving the submandibular, sublingual, and submental fascial spaces , historically associated with a mortality rate exceeding 50% prior to modern airway intervention and antimicrobial therapy.

Pathogenesis & Anatomic Vulnerability

More than 80% to 90% of cases arise from an odontogenic source , most commonly an untreated periapical abscess or dental extraction of the mandibular second or third molars .

Anatomical Landmark : The roots of the mandibular second and third molars extend deeply into the mandible, lying inferior to the mylohyoid muscle ridge (line) . Consequently, an infection eroding through the thin lingual cortical plate of the mandible drains directly into the submandibular space rather than staying confined to the oral cavity, spreading rapidly across the midline to involve all contiguous fascial compartments.

Microbiology is typically polymicrobial, reflecting mixed normal oral flora: viridans streptococci ( Streptococcus anginosus group), Peptostreptococcus , Bacteroides , Prevotella , Porphyromonas , and Fusobacterium nucleatum .

Clinical Presentation & Red Flags

Severe neck pain, throat pain, dysphagia, odynophagia, and trismus.

Woody / Brawny Induration : Symmetrical, firm, non-fluctuant, tense, tender "woody" swelling of the bilateral submandibular and submental regions, producing a characteristic thick-necked or "bull neck" appearance.

Floor of the Mouth Elevation : The sublingual space infection elevates the floor of the mouth, forcing the tongue to protrude superiorly and posteriorly against the hard and soft palate , completely obstructing the oropharynx.

Airway Compromise Signs : Drooling (inability to swallow secretions), muffled "hot potato" voice, dyspnea, tachypnea, stridor, tripoding posture, and cyanosis.

Emergency Management Protocol

Definitive Airway Control (The Paramount Priority) :

Call immediately for emergency anesthesia and ENT / oral maxillofacial surgery assistance.

Blind oral or blind nasotracheal intubation is strictly contraindicated! Attempts at standard direct laryngoscopy or blind intubation frequently fail due to severe lingual displacement and pharyngeal edema, and can trigger fatal laryngospasm, rupture of phlegmon with purulent aspiration, or complete irreversible airway obstruction.

Airway of choice: Awake fiberoptic nasotracheal intubation performed in the operating room, or emergent surgical airway (awake tracheostomy or cricothyroidotomy) under local anesthesia.

Broad-Spectrum Intravenous Antimicrobials :

Initiate immediate high-dose IV empiric coverage targeting oral Gram-positive aerobes, anaerobes, and potential resistant pathogens:

• Preferred First-Line : Intravenous Ampicillin-Sulbactam (Unasyn) 3 grams IV every 6 hours ; OR
• Alternative : Intravenous Ceftriaxone 2 grams daily PLUS Intravenous Metronidazole 500 mg every 8 hours ;

In Penicillin-Allergic or Suspected MRSA : Intravenous Vancomycin (15 to 20 mg/kg IV every 12 hours) PLUS Intravenous Metronidazole (500 mg IV every 8 hours) PLUS Intravenous Cefepime (2 g IV every 8 hours) or Levofloxacin (750 mg IV daily) .

Surgical Decompression & Source Control :

Emergent operative exploration for external fascial incision, wide bilateral submandibular decompression, drainage of any localized collections, and extraction of the offending infected molar.

Oral Mucosal Ulcerations: Differential Diagnosis & Management

Oral mucosal ulcers are among the most frequent oral complaints in primary care. Establishing the precise anatomical location (keratinized vs. non-keratinized mucosa), morphology, scrapability, and recurrence pattern allows rapid differentiation between aphthous ulcers, herpes simplex virus, and candidiasis.

1. Recurrent Aphthous Stomatitis (RAS / Canker Sores)

Epidemiology & Pathophysiology : The most common ulcerative disease of the oral mucosa, affecting up to 20% of the population. Mediated by an abnormal T-cell (CD8+ cytotoxic) immune response directed against oral keratinocytes, triggered by local mucosal microtrauma (accidental biting, hard toothbrushes), emotional stress, systemic illness, hormonal fluctuations, or sodium lauryl sulfate in commercial dentifrices.

Clinical Subtypes :

Minor Aphthae (80% to 85%) : Small (<1 cm diameter, typically 2 to 5 mm), shallow, round-to-oval ulcers with a gray-yellow fibrinous pseudomembranous necrotic base surrounded by a prominent, sharply demarcated erythematous inflammatory halo . Extremely painful. Resolve spontaneously within 7 to 14 days without scarring.

Major Aphthae (Sutton Disease, 10% to 15%) : Large (>1 cm diameter), deep, punched-out, crateriform ulcers with elevated borders. Extremely painful, persisting for 2 to 6 weeks or months, and frequently heal with permanent scar formation and tissue distortion.

Herpetiform Aphthae (5% to 10%) : Crops of numerous (10 to 100) tiny, pinpoint (1 to 3 mm) shallow ulcers that coalesce into irregular ragged ulcerated plaques. Important : Despite the name, they are not caused by herpes simplex virus and do not display a vesicular stage.

Anatomic Hallmark : Aphthous ulcers occur STRICTLY ON NON-KERATINIZED, MOBILE ORAL MUCOSA :

• Buccal mucosa (inner cheeks);
• Labial mucosa (inner lips);
• Ventral surface of the tongue;

Floor of the mouth and soft palate.

Exam Pearl : Aphthous ulcers never occur on keratinized mucosa (vermilion border, hard palate, attached gingiva) in immunocompetent hosts.

Evidence-Based Pharmacotherapy :

Topical High-Potency Corticosteroids (First-Line) :

Triamcinolone acetonide 0.1% dental paste (Kenalog in Orabase) : Applied directly to the dried ulcer 2 to 4 times daily after meals and at bedtime until healed;

Fluocinonide 0.05% gel or Clobetasol propionate 0.05% gel/ointment for refractory or major aphthae;

Topical Analgesics & Protectants : Viscous lidocaine 2% solution applied locally with a cotton swab before meals; over-the-counter benzocaine 10% to 20% gel; oral sucralfate slurry swish and spit;

Antiseptic Rinses : Chlorhexidine gluconate 0.12% oral rinse twice daily to prevent secondary bacterial superinfection.

Systemic Screening in Complex / Severe / Recurrent Aphthae :

While isolated minor aphthae require no laboratory workup, patients with severe, recurrent, or atypical aphthae should be evaluated for underlying systemic diseases:

Behçet Disease : Triad of recurrent oral aphthae (≥3 times in 12 months) PLUS recurrent genital aphthae, ocular uveitis/retinal vasculitis, and cutaneous lesions (erythema nodosum, pathergy test positive);

Celiac Disease : Screen with serum tissue transglutaminase IgA (tTG-IgA);

Inflammatory Bowel Disease (Crohn Disease) : Aphthous ulcers, abdominal pain, diarrhea, elevated fecal calprotectin;

• Micronutrient Deficiencies : Serum Vitamin B12, folate, ferritin / iron saturation, and zinc levels;
• HIV Infection : Screen in high-risk patients or persistent giant major aphthae;

PFAPA Syndrome : In pediatric patients with Periodic Fevers, Aphthous stomatitis, Pharyngitis, and cervical Adenitis.

2. Herpes Simplex Virus Gingivostomatitis (HSV-1)

Clinical Presentation : Primary infection typically occurs in young children (aged 6 months to 5 years) or young adults, presenting with high fever, malaise, irritability, cervical lymphadenopathy, and intense oral pain. It begins as crops of multiple small vesicles (1 to 2 mm) that rapidly rupture within 24 hours, coalescing into painful, shallow, clustered erosions with irregular, scalloped borders.

Anatomic Hallmark : HSV characteristically targets KERATINIZED, BOUND MUCOSA :

• Vermilion border of the lips (herpes labialis / "cold sores");
• Hard palate;

Attached gingiva (diffusely erythematous, friable, edematous, bleeding gingiva is classic for primary herpetic gingivostomatitis).

Pharmacotherapy :

Systemic antiviral therapy is most effective when initiated within 72 hours of symptom onset :

Oral Valacyclovir : 1,000 mg orally twice daily for 7 to 10 days (or 2,000 mg BID for 1 day for recurrent herpes labialis);

Oral Acyclovir : 400 mg orally three times daily (or 200 mg 5 times daily) for 7 to 10 days;

Supportive care: Hydration, oral analgesics (acetaminophen, ibuprofen), and barrier protectants.

3. Oral Candidiasis (Thrush)

Etiology & Risk Factors : Overgrowth of the opportunistic fungal commensal Candida albicans , triggered by:

Inhaled corticosteroid use (especially metered-dose inhalers used without a valved holding chamber / spacer or without post-inhalation mouth rinsing);

• Recent systemic broad-spectrum antibiotic therapy;
• Denture wear (denture stomatitis);
• Salivary hypofunction (xerostomia, Sjögren syndrome);

Immunocompromised states: poorly controlled diabetes mellitus, chemotherapy, systemic corticosteroid therapy, hematologic malignancy, advanced HIV/AIDS (CD4 <200 cells/mcL).

Clinical Forms & Scrapability Hallmark :

Pseudomembranous Candidiasis (Classic Thrush) : Hallmark creamy, curd-like white plaques on the buccal mucosa, tongue, soft palate, and pharynx. Diagnostic Hallmark: THE WHITE PLAQUES CAN BE WIPED OFF WITH A TONGUE BLADE OR GAUZE , revealing an underlying erythematous, raw, inflamed, and sometimes bleeding mucosal surface.

Distinction from Oral Leukoplakia : Leukoplakia presents as chronic, hyperkeratotic white patches on the lateral tongue or oral mucosa that CANNOT be wiped or scraped off , representing premalignant dysplastic squamous changes requiring biopsy.

Erythematous (Atrophic) Candidiasis : Bright red, velvety, painful mucosal depapillation on the dorsal tongue or beneath maxillary dentures.

Angular Cheilitis (Perleche) : Erythema, maceration, fissuring, and scaling at the oral commissures (lip corners), often coinfected with Staphylococcus aureus .

Pharmacotherapy :

Mild, Localized Disease :

Nystatin oral suspension (100,000 units/mL) : 4 to 6 mL swish and swallow four times daily (QID) for 7 to 14 days; OR

Clotrimazole troches (10 mg) : One troche dissolved slowly in the mouth 5 times daily for 7 to 14 days;

Moderate-to-Severe, Refractory, or Immunocompromised Host :

Oral Fluconazole : 200 mg loading dose on day 1, followed by 100 to 200 mg orally once daily for 7 to 14 days (provides systemic bioavailability and treats concomitant esophageal candidiasis);

Denture Stomatitis : The patient must remove dentures at night, clean them thoroughly, and soak them overnight in a chlorhexidine gluconate or antifungal solution; treating the oral mucosa alone will result in immediate reinfection from colonized acrylic dentures;

Inhaled Corticosteroid Counseling : Always utilize a valved holding chamber (spacer) and aggressively swish, gargle, and spit tap water immediately following every dose.

Diagnostic Comparison of Common Oral Mucosal Lesions

Feature Recurrent Aphthous Stomatitis HSV Gingivostomatitis Oral Candidiasis (Thrush) Oral Leukoplakia

Typical Location Non-keratinized mobile mucosa (buccal, labial, ventral tongue) Keratinized bound mucosa (hard palate, attached gingiva, lips) Buccal mucosa, tongue, soft palate, oropharynx Lateral tongue, floor of mouth, buccal mucosa

Primary Morphology Shallow, discrete round ulcers; gray-yellow base with red halo Grouped vesicles that rupture into irregular scalloped erosions Creamy white, curd-like pseudomembranous plaques Well-demarcated, flat, smooth or wrinkled white plaques

Scrapability Ulcerated (cannot scrape) Eroded (cannot scrape) WIPES OFF EASILY , leaving red bleeding base CANNOT BE WIPED OFF

Systemic Symptoms Absent in simple minor aphthae High fever, malaise, cervical adenopathy Absent (unless severe underlying disease) Absent

First-Line Therapy Topical triamcinolone in Orabase (0.1%) Oral valacyclovir or acyclovir (within 72h) Oral nystatin swish & swallow or oral fluconazole Incisional biopsy to evaluate for dysplasia/carcinoma

Loading diagram... Diagnostic & Triage Algorithm for Acute Odontogenic Pain, Swelling & Oral Ulcers